| 1 |
35568782 | EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells. | 2022 May 14 |
3 |
| 2 |
34290403 | EGFR activation limits the response of liver cancer to lenvatinib. | 2021 Jul |
1 |
| 3 |
34330780 | EGFR Inhibitors Synergize with Lenvatinib for Liver Cancer Treatment. | 2021 Sep |
1 |
| 4 |
32382022 | Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells. | 2020 May 7 |
2 |
| 5 |
30860683 | Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro. | 2019 Feb |
1 |
| 6 |
29517103 | Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo. | 2018 May |
1 |
| 7 |
21551260 | E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptor. | 2011 Jul |
1 |